Chemical inhibitors of Mast Cell Protease encompass a variety of compounds that directly interfere with the protein's enzymatic activity. Gabexate Mesilate and Nafamostat Mesilate, both synthetic serine protease inhibitors, inhibit Mast Cell Protease by binding to the enzyme's active site, which blocks substrate access and consequently halts its proteolytic function. This mode of inhibition is also employed by Benzamidine, an inhibitor that competes with natural substrates for binding to the active site, thereby impeding the protease's ability to process substrates. Aprotinin, although a small protein, functions similarly by forming stable complexes with Mast Cell Protease, which results in the inhibition of the protein's enzymatic activity. In a comparable manner, Chymostatin, a peptide aldehyde, forms a covalent bond with the serine residue within the active site of Mast Cell Protease, leading to the enzyme's inactivation.
In addition to these, Marimastat, which primarily targets matrix metalloproteinases, can interact with the active site of Mast Cell Protease and inhibit its activity. While Pepstatin A is an aspartic protease inhibitor, it may engage Mast Cell Protease by binding to similar domains, thereby reducing its activity. The irreversible inhibitor E-64 operates by covalently attaching to the active site of cysteine residues, a mechanism that can extend to the inhibition of Mast Cell Protease. AEBSF, another irreversible inhibitor, modifies the active site serine of Mast Cell Protease, leading to a cessation of its proteolytic activity. Similarly, Camostat Mesilate forms a stable complex with Mast Cell Protease, directly inhibiting its function. Tranexamic Acid, an antifibrinolytic agent, inhibits proteases by blocking the lysine binding sites, which can obstruct the activity of Mast Cell Protease. Lastly, Leupeptin, a reversible inhibitor of both serine and cysteine proteases, exerts its inhibitory effect by binding to the active site of Mast Cell Protease, preventing it from engaging with its substrates and performing its proteolytic role. Each of these chemicals interacts with Mast Cell Protease in a manner that leads to the inhibition of its proteolytic capabilities, underscoring the direct impact these compounds have on the functionality of the protein.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
This synthetic serine protease inhibitor directly inhibits Mast Cell Protease by binding to its active site, preventing substrate access. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
As a potent serine protease inhibitor, this chemical directly inhibits Mast Cell Protease by blocking its enzymatic activity. | ||||||
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
This reversible inhibitor of serine proteases competitively inhibits Mast Cell Protease by interfering with substrate binding. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
This small protein acts as a protease inhibitor by forming stable complexes with Mast Cell Protease, thereby inhibiting its function. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
This peptide aldehyde inhibits Mast Cell Protease by binding covalently to the serine residue in the active site of the enzyme. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Though primarily a matrix metalloproteinase inhibitor, it can inhibit Mast Cell Protease by binding to its active site. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
This is an irreversible cysteine protease inhibitor that can inhibit Mast Cell Protease by covalently binding to its active site. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
This irreversible serine protease inhibitor covalently modifies the active site serine of Mast Cell Protease, inhibiting its function. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
This synthetic serine protease inhibitor directly inhibits Mast Cell Protease by forming a stable complex with the enzyme. | ||||||
Tranexamic acid | 1197-18-8 | sc-204921 sc-204921A | 5 g 10 g | $29.00 $50.00 | 10 | |
This antifibrinolytic agent inhibits proteases by blocking the lysine binding sites, which may impede Mast Cell Protease activity. | ||||||